LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services. The Home Health segment offers a wide range of services, including skilled nursing, private duty nursing, physical, occupational and speech therapy, medically-oriented social services and hospice care. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel by operating an institutional pharmacy, which focuses on providing a full array of services to long term acute care hospitals. LHC Group was founded by Keith G. Myers in September 1994 and is headquartered in Lafayette, LA.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Services
SectorMedical
Phone337-233-1307
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.81 billion
Profitability
Miscellaneous
Employees14,554
Next Earnings Date5/1/2019 (Estimated)
OptionableOptionable
LHC Group (NASDAQ:LHCG) Frequently Asked Questions
What is LHC Group's stock symbol?
LHC Group trades on the NASDAQ under the ticker symbol "LHCG."
How were LHC Group's earnings last quarter?
LHC Group, Inc. (NASDAQ:LHCG) released its earnings results on Wednesday, February, 27th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01. The health services provider earned $509.80 million during the quarter, compared to analysts' expectations of $522.21 million. LHC Group had a net margin of 3.50% and a return on equity of 8.40%. The firm's revenue was up 75.1% on a year-over-year basis. During the same period last year, the business earned $0.62 earnings per share. View LHC Group's Earnings History.
When is LHC Group's next earnings date?
What guidance has LHC Group issued on next quarter's earnings?
LHC Group updated its FY19 earnings guidance on Wednesday, February, 27th. The company provided earnings per share guidance of $4.15-4.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.18. The company issued revenue guidance of $2.08-2.13 billion, compared to the consensus revenue estimate of $2.16 billion.
What price target have analysts set for LHCG?
12 brokerages have issued 1 year price objectives for LHC Group's stock. Their forecasts range from $101.00 to $130.00. On average, they expect LHC Group's share price to reach $114.0909 in the next twelve months. This suggests a possible upside of 1.0% from the stock's current price. View Analyst Price Targets for LHC Group.
What is the consensus analysts' recommendation for LHC Group?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LHC Group.
Has LHC Group been receiving favorable news coverage?
Press coverage about LHCG stock has trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. LHC Group earned a daily sentiment score of 1.4 on InfoTrie's scale. They also assigned news headlines about the health services provider a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
Who are some of LHC Group's key competitors?
Some companies that are related to LHC Group include Teleflex (TFX), Hologic (HOLX), DexCom (DXCM), Sunny Optical Technology (Group) (SNPTF), Ramsay Health Care Limited Fully Paid Ord. Shrs (RHC), GRIFOLS S A/S (GRFS), SYSMEX CORP/ADR (SSMXY), Straumann (SAUHF), Smith & Nephew (SN), SONOVA HLDG AG/ADR (SONVY), Varian Medical Systems (VAR), Seattle Genetics (SGEN), EXACT Sciences (EXAS), WellCare Health Plans (WCG) and Quest Diagnostics (DGX).
What other stocks do shareholders of LHC Group own?
Who are LHC Group's key executives?
LHC Group's management team includes the folowing people:
- Keith G. Myers, Chairman & Chief Executive Officer
- Donald Dwayne Stelly, President & Chief Operating Officer
- Joshua L. Proffitt, CFO, Secretary, Treasurer, EVP & General Counsel
- Angie M. Begnaud, Chief Clinical Officer & Executive Vice President
- John M. Thompson, Chief Information Officer & Senior Vice President
Who are LHC Group's major shareholders?
LHC Group's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.55%), Dimensional Fund Advisors LP (6.44%), FMR LLC (3.58%), Bank of New York Mellon Corp (2.28%), Norges Bank (1.75%) and Northern Trust Corp (1.70%). Company insiders that own LHC Group stock include Coliseum Capital Management, L, Donald Dwayne Stelly, Jeff Reibel, Joshua L Proffitt, Keith G Myers and Tyree G Wilburn. View Institutional Ownership Trends for LHC Group.
Which institutional investors are selling LHC Group stock?
LHCG stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Polar Capital LLP, Lisanti Capital Growth LLC, Columbus Circle Investors, New York State Common Retirement Fund, First Trust Advisors LP, Timpani Capital Management LLC and Penn Capital Management Co. Inc.. Company insiders that have sold LHC Group company stock in the last year include Donald Dwayne Stelly, Jeff Reibel, Joshua L Proffitt, Keith G Myers and Tyree G Wilburn. View Insider Buying and Selling for LHC Group.
Which institutional investors are buying LHC Group stock?
LHCG stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, FMR LLC, BlackRock Inc., Castleark Management LLC, Trillium Asset Management LLC, GW&K Investment Management LLC, Thrivent Financial for Lutherans and SG Americas Securities LLC. View Insider Buying and Selling for LHC Group.
How do I buy shares of LHC Group?
Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is LHC Group's stock price today?
One share of LHCG stock can currently be purchased for approximately $112.95.
How big of a company is LHC Group?
LHC Group has a market capitalization of $3.55 billion and generates $1.81 billion in revenue each year. The health services provider earns $63.57 million in net income (profit) each year or $3.55 on an earnings per share basis. LHC Group employs 14,554 workers across the globe.
What is LHC Group's official website?
How can I contact LHC Group?
LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at 337-233-1307 or via email at [email protected]
MarketBeat Community Rating for LHC Group (NASDAQ LHCG)
MarketBeat's community ratings are surveys of what our community members think about LHC Group and other stocks. Vote "Outperform" if you believe LHCG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LHCG will underperform the S&P 500 over the long term. You may vote once every thirty days.
